Dipna Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 24.05 Cr
as on 16-11-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.38 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.20 Cr
as on 16-11-2024
About Dipna Pharmachem
The Corporate was formerly known as Dipan Pharmachem Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 24.05 Cr.
The company currently has active open charges totaling ₹11.38 Cr. The company has closed loans amounting to ₹4.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Dipna Pharmachem Limited India are Madhuri Gurwani as COMPANY SECRETARY and Madhuri Gurwani as Company Secretary. Dipna Shah, Keyur Shah, Nirav Soni, and One other member serve as directors at the Company.
- CIN/LLPIN
L24100GJ2011PLC066400
- Company No.
066400
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2011
- Date of AGM
27 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dipna Pharmachem?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhuri Gurwani | Company Secretary | Current | |
Keyur Shah  | Managing Director | 19-Jul-2011 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirav Soni | Additional Director | 16-Oct-2024 | Current |
| Dipna Shah | Director | 19-Jul-2011 | Current |
| Nandish Jani | Director | 01-May-2022 | Current |
Financial Performance of Dipna Pharmachem.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dipna Pharmachem?
Unlock access to Dipna Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Oct 2022 | ₹9.00 Cr | Open |
Others Creation Date: 29 Oct 2022 | ₹2.30 M | Open |
Others Creation Date: 09 Jun 2021 | ₹2.15 Cr | Open |
How Many Employees Work at Dipna Pharmachem?
Unlock and access historical data on people associated with Dipna Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dipna Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dipna Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
